Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Algeria
Algeria: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 95.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Algeria, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Algeria is 95.0%, measured in 2025. That is the highest value across all 18 years on record.
The figure is up 5.6% on the previous year and up 14.5% over five years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Algeria peaked at 95.0% in 2025 and was at its lowest, 0.0%, in 2008.
That places Algeria 38th out of 194 countries with data for 2025, putting it in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 32.8% | 0.0% | 91.0% | 10 |
| 2020s | 84.8% | 74.0% | 95.0% | 6 |
Countries ranked near Algeria
More health data for Algeria
- Heat deaths vs projected death rates 943.1 (2090)
- Un projection of annual infant deaths 1,455 (2100)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 08, male, interpolated 516,609 (2025)
- Population, male 51.0% (2025)
- Population ages 15-64, female 14.63 million (2025)
- Population ages 0-14, total 14.20 million (2025)
- Age population, age 06, female, interpolated 485,768 (2025)
- Age population, age 06, male, interpolated 505,949 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Algeria?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Algeria was 95.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Algeria?
- The highest recorded value was 95.0% in 2025.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Algeria?
- The lowest recorded value was 0.0% in 2008.
- How does Algeria rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Algeria ranks 38th out of 194 countries with data for 2025.
- Where does this Algeria data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).